SCHEMBL16812633

SCHEMBL16812633

CC1CN(c2ccc(CN3CCC(NC(=O)c4cccc(-c5ccc(OC(F)(F)F)cc5)c4F)CC3)cn2)CC(C)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 3/20 0.48
▸ PGR P06401 1/20 0.48
▸ GPR183 P32249 1/20 0.48
▸ DRD4 P21917 2/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ CHRM2 P08172 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ CHRM4 P08173 3/20 0.45
▸ SSTR5 P35346 1/20 0.45
▸ PDE4B Q07343 6/20 0.45
▸ CCR3 P51677 1/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ PRKAB2 O43741 1/20 0.43
▸ PRKAG1 P54619 1/20 0.43
▸ PRKAA2 P54646 1/20 0.43
▸ PRKAA1 Q13131 1/20 0.43
▸ PRKAG3 Q9UGI9 1/20 0.43
▸ PRKAG2 Q9UGJ0 1/20 0.43
▸ PRKAB1 Q9Y478 1/20 0.43
▸ PDE4D Q08499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16812557 0.94 SMO (0.56) SMOPGRGPR183DRD4HTR2A
SCHEMBL16812637 0.93 SMO (0.47) SMOPGRGPR183DRD4HTR2A
SCHEMBL16812558 0.92 SMO (0.59) SMOPGRGPR183DRD4HTR2A
SCHEMBL18286584 0.91 CHRM4 (0.49) SMOPGRGPR183DRD4HTR2A
SCHEMBL16812615 0.90 PRKAA2 (0.50) SMOPGRGPR183DRD4HTR2A
SCHEMBL16812755 0.90 HPGDS (0.49) SMOPGRGPR183DRD4HTR2A
SCHEMBL16812619 0.90 SMO (0.48) SMOPGRGPR183DRD4HTR2A
SCHEMBL16811977 0.90 DRD4 (0.49) SMODRD4SSTR5PDE4BCCR3
SCHEMBL16812756 0.89 HPGDS (0.49) SMOPGRGPR183DRD4HTR2A
SCHEMBL18286595 0.88 SMO (0.54) SMODRD4HTR2ACHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885PGR 3016/4885GPR183 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback